- Home
- KNDI vs ONCY Comparison
KNDI vs ONCY Comparison
Compare KNDI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- ONCY
- Stock Information
- Founded
- KNDI 2002
- ONCY 1998
- Country
- KNDI China
- ONCY Canada
- Employees
- KNDI N/A
- ONCY N/A
- Industry
- KNDI Auto Manufacturing
- ONCY Pharmaceuticals and Biotechnology
- Sector
- KNDI Consumer Discretionary
- ONCY Health Care
- Exchange
- KNDI Nasdaq
- ONCY Nasdaq
- Market Cap
- KNDI 109.2M
- ONCY 89.7M
- IPO Year
- KNDI N/A
- ONCY 1999
- Fundamental
- Price
- KNDI $1.14
- ONCY $0.86
- Analyst Decision
- KNDI
- ONCY Strong Buy
- Analyst Count
- KNDI 0
- ONCY 4
- Target Price
- KNDI N/A
- ONCY $4.33
- AVG Volume (30 Days)
- KNDI 115.9K
- ONCY 910.9K
- Earning Date
- KNDI 08-19-2025
- ONCY 08-08-2025
- Dividend Yield
- KNDI N/A
- ONCY N/A
- EPS Growth
- KNDI N/A
- ONCY N/A
- EPS
- KNDI N/A
- ONCY N/A
- Revenue
- KNDI $127,569,613.00
- ONCY N/A
- Revenue This Year
- KNDI N/A
- ONCY N/A
- Revenue Next Year
- KNDI N/A
- ONCY N/A
- P/E Ratio
- KNDI N/A
- ONCY N/A
- Revenue Growth
- KNDI 3.21
- ONCY N/A
- 52 Week Low
- KNDI $0.89
- ONCY $0.33
- 52 Week High
- KNDI $2.07
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- KNDI 45.50
- ONCY 41.07
- Support Level
- KNDI $1.10
- ONCY $0.80
- Resistance Level
- KNDI $1.30
- ONCY $0.99
- Average True Range (ATR)
- KNDI 0.05
- ONCY 0.10
- MACD
- KNDI -0.01
- ONCY -0.05
- Stochastic Oscillator
- KNDI 17.39
- ONCY 12.98
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.